Examining Risk Factors Accelerating Time-to-Chronic Obstructive Pulmonary Disease (COPD) Diagnosis among Asthma Patients-Reference-Cited by-同舟云学术

Examining Risk Factors Accelerating Time-to-Chronic Obstructive Pulmonary Disease (COPD) Diagnosis among Asthma Patients

Published:2022-01-10 Issue:1 Volume:19 Page:47-56
ISSN:1541-2555
Container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease

Author:

Asamoah-Boaheng Michael¹^ORCID,Farrell Jamie²^ORCID,Osei Bonsu Kwadwo³^ORCID,Midodzi William K.¹^ORCID

Affiliation:

1. Faculty of Medicine, Division of Community Health and Humanity, Clinical Epidemiology Unit, Memorial University of Newfoundland, St. John’s, NL, Canada

2. Faculty of Medicine, Division of Respirology, Memorial University of Newfoundland, St. John’s, NL, Canada

3. School of Pharmacy, Memorial University of Newfoundland, St. John’s, NL, Canada

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15412555.2021.2024159

Reference48 articles.

1. World Health Organization (WHO). Asthma: key facts 2021. [Internet]. [cited 2021 Aug 9]. Available from: https://www.who.int/news-room/fact-sheets/detail/asthma.

2. Epidemiology of Asthma in Children and Adults

3. Asthma as a Risk Factor for COPD in a Longitudinal Study

4. The association between childhood asthma and adult chronic obstructive pulmonary disease

5. Outcomes of Childhood Asthma and Wheezy Bronchitis. A 50-Year Cohort Study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plackett–Burman and face-centered composite designs for development and optimization of chromatographic method for the simultaneous determination of glycopyrronium, indacaterol and mometasone in their fixed dose combination inhaler – Green profile assessment;Journal of Pharmaceutical and Biomedical Analysis;2023-09